SigTuple

Executive Summary

SigTuple is an Indian AI-driven diagnostics company founded in 2020 that automates medical image analysis for pathology, hematology, and ophthalmology. Its deep-learning platform interprets microscopy and imaging data to deliver rapid, high-accuracy results, aiming to improve diagnostic efficiency and reduce turnaround times for hospitals and labs. With $40 million raised and a platform-stage status, SigTuple has built a scalable solution addressing critical bottlenecks in clinical diagnostics. The company’s technology covers a range of specialties, positioning it as a versatile player in the growing AI diagnostics market. Despite its private status, SigTuple’s strong funding and focus on high-volume imaging suggest potential for expansion into new geographies and clinical areas, though financial details and commercial traction remain opaque.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Hematology Analyzer60% success
• Q2 2026Strategic Partnership with Major Indian Hospital Chain75% success
• Q4 2026Launch of AI-Powered Retinal Screening Module55% success